NDAINJECTIONINJECTABLE
Approved
Dec 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sodium Chromate CR-51 is a radioactive diagnostic agent used for nuclear medicine imaging studies. It is administered by injection to visualize blood pool and organ perfusion. This radiopharmaceutical is used primarily in clinical diagnostics rather than therapeutic applications.
LOE Approaching
Niche diagnostic radiopharmaceutical with LOE approaching; limited commercial team expansion expected and likely focused on market maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Sodium Chromate CR-51 offers limited career growth opportunities given its niche market and LOE-approaching lifecycle stage. Roles are primarily focused on maintaining market share in nuclear medicine diagnostics rather than building new franchises.
Nuclear Medicine SpecialistRadiopharmaceutical Technician
Worked on SODIUM CHROMATE CR 51 at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.